Abbvie Financial Statements From 2010 to 2022

ABBV
 Stock
  

USD 153.93  0.13  0.08%   

Abbvie financial statements provide useful quarterly and yearly information to potential Abbvie Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Abbvie financial statements helps investors assess Abbvie's valuation, profitability, and current liquidity needs.
There are over one hundred fifteen available fundamental signals for Abbvie Inc, which can be analyzed over time and compared to other ratios. Please make sure you validate Abbvie's prevailing fundamental trends against the trends from 2010 to 2022 to make sure the company is sustainable.
Abbvie Average Assets are fairly stable at the moment as compared to the past year. Abbvie reported Average Assets of 148.47 Billion in 2021. Earnings Before Interest Taxes and Depreciation Amortization EBITDA is likely to climb to about 25.8 B in 2022, whereas Revenue Per Employee is likely to drop slightly above 970.2 K in 2022.
  
Refresh
Check Abbvie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbvie main balance sheet or income statement drivers, such as Direct Expenses of 18.8 B, Consolidated Income of 9.3 B or Cost of Revenue of 18.8 B, as well as many exotic indicators such as Interest Coverage of 7.71, Long Term Debt to Equity of 4.56 or Calculated Tax Rate of 11.91. Abbvie financial statements analysis is a perfect complement when working with Abbvie Valuation or Volatility modules. It can also supplement various Abbvie Technical models. Please continue to the analysis of Abbvie Correlation against competitors.

Abbvie Revenues

46.38 Billion

Share

Abbvie Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets116 B146.5 B67.3 B
Increasing
Slightly volatile
Cash and Equivalents11 B9.7 B9.5 B
Increasing
Slightly volatile
Investments370.5 M361 MB
Decreasing
Stable
Investments Current86.2 M84 M497.9 M
Decreasing
Slightly volatile
Investments Non Current284.3 M277 M551.7 M
Increasing
Stable
Property Plant and Equipment Net4.4 B5.1 B3.1 B
Increasing
Slightly volatile
Inventory2.6 B3.1 B1.7 B
Increasing
Slightly volatile
Tax Assets924.3 M806.4 MB
Decreasing
Slightly volatile
Trade and Non Trade Receivables8.4 B10 B5.5 B
Increasing
Slightly volatile
Trade and Non Trade Payables18.2 B22.7 B11.1 B
Increasing
Slightly volatile
Goodwill and Intangible Assets116.9 B108.3 B44.2 B
Increasing
Slightly volatile
Total Liabilities105.4 B131.1 B61.9 B
Increasing
Slightly volatile
Shareholders Equity16.6 B15.4 B5.8 B
Increasing
Very volatile
Accumulated Retained Earnings Deficit3.3 B3.1 B2.7 B
Increasing
Slightly volatile
Current Assets26.7 B27.9 B20.2 B
Increasing
Slightly volatile
Assets Non Current128 B118.6 B50 B
Increasing
Slightly volatile
Current Liabilities38 B35.2 B16.1 B
Increasing
Slightly volatile
Liabilities Non Current78.2 B95.9 B46.7 B
Increasing
Slightly volatile
Tax Liabilities2.8 BB2.1 B
Increasing
Slightly volatile
Total Debt62.5 B76.7 B37.2 B
Increasing
Slightly volatile
Debt Current13.5 B12.5 B4.5 B
Increasing
Slightly volatile
Debt Non Current53.6 B64.2 B33 B
Increasing
Slightly volatile
Shareholders Equity USD16.6 B15.4 B5.8 B
Increasing
Very volatile
Cash and Equivalents USD11 B9.7 B9.5 B
Increasing
Slightly volatile
Total Debt USD62.5 B76.7 B37.2 B
Increasing
Slightly volatile
Accounts Payable10.2 B9.5 B4.6 B
Increasing
Slightly volatile
Receivables10.8 B10 B5.6 B
Increasing
Slightly volatile
Inventories3.4 B3.1 B1.8 B
Increasing
Slightly volatile

Abbvie Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues46.4 B56.2 B29.5 B
Increasing
Slightly volatile
Cost of Revenue18.8 B17.4 B8.2 B
Increasing
Slightly volatile
Selling General and Administrative Expense10.7 B12.3 B7.5 B
Increasing
Slightly volatile
Research and Development Expense6.7 B7.1 BB
Increasing
Slightly volatile
Operating Expenses18.4 B20.8 B13.1 B
Increasing
Slightly volatile
Interest Expense2.6 B2.4 BB
Increasing
Slightly volatile
Income Tax Expense1.6 B1.4 B799.4 M
Increasing
Very volatile
Consolidated Income9.3 B11.5 B5.7 B
Increasing
Slightly volatile
Net Income to Non Controlling Interests7.4 MM6.2 M
Increasing
Slightly volatile
Net Income9.3 B11.5 B5.6 B
Increasing
Slightly volatile
Net Income Common Stock9.3 B11.5 B5.6 B
Increasing
Slightly volatile
Weighted Average Shares1.9 B1.8 B1.6 B
Increasing
Slightly volatile
Weighted Average Shares Diluted1.9 B1.8 B1.6 B
Increasing
Slightly volatile
Earning Before Interest and Taxes EBIT12.3 B15.4 B7.4 B
Increasing
Slightly volatile
Revenues USD46.4 B56.2 B29.5 B
Increasing
Slightly volatile
Net Income Common Stock USD9.3 B11.5 B5.6 B
Increasing
Slightly volatile
Earning Before Interest and Taxes USD12.3 B15.4 B7.4 B
Increasing
Slightly volatile
Gross Profit32.8 B38.8 B21.6 B
Increasing
Slightly volatile
Operating Income14.4 B17.9 B8.6 B
Increasing
Slightly volatile
Direct Expenses18.8 B17.4 B8.2 B
Increasing
Slightly volatile

Abbvie Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow Investment Acquisitions and Disposals(21.6 M)(21 M)67 M
Increasing
Slightly volatile
Net Cash Flow from Financing(19.5 B)(19 B)(5.2 B)
Decreasing
Slightly volatile
Issuance Repayment of Debt Securities (8.6 B)(8.4 B)5.9 B
Decreasing
Slightly volatile
Issuance Purchase of Equity Shares(744.5 M)(690 M)(2.3 B)
Decreasing
Stable
Net Cash Flow from Investing(2.5 B)(2.3 B)(4.9 B)
Decreasing
Slightly volatile
Net Cash Flow from Operations18 B22.8 B10.6 B
Increasing
Slightly volatile
Effect of Exchange Rate Changes on Cash (104.7 M)(97 M)(106.7 M)
Increasing
Very volatile
Net Cash Flow or Change in Cash and Cash Equivalents1.1 B1.3 B831.4 M
Decreasing
Very volatile
Share Based Compensation579.9 M692 M372.5 M
Increasing
Slightly volatile
Depreciation Amortization and Accretion9.2 B8.5 B2.8 B
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share5.386.483.4672
Increasing
Slightly volatile
Earnings per Diluted Share5.366.453.4541
Increasing
Slightly volatile
Earnings per Basic Share USD5.386.483.4672
Increasing
Slightly volatile
Dividends per Basic Common Share4.535.22.8647
Increasing
Slightly volatile
Return on Average Equity0.90.8360.4132
Decreasing
Stable
Return on Average Assets0.08740.0780.1126
Decreasing
Slightly volatile
Return on Invested Capital0.210.1980.2793
Decreasing
Slightly volatile
Gross Margin0.680.690.7428
Decreasing
Slightly volatile
Profit Margin0.190.2050.1957
Decreasing
Stable
EBITDA Margin0.410.4250.3299
Increasing
Slightly volatile
Return on Sales0.250.2730.2531
Decreasing
Very volatile
Asset Turnover0.430.3790.5652
Decreasing
Slightly volatile
Payout Ratio0.960.8020.8689
Increasing
Slightly volatile
Enterprise Value over EBITDA14.2612.8916.5685
Increasing
Very volatile
Enterprise Value over EBIT24.4820.022.268
Increasing
Slightly volatile
Price to Earnings Ratio22.5320.89525.4242
Increasing
Very volatile
Sales per Share27.1131.7518.1326
Increasing
Slightly volatile
Price to Sales Ratio4.114.2654.4068
Decreasing
Slightly volatile
Price to Book Value15.3315.53617.2574
Decreasing
Slightly volatile
Debt to Equity Ratio6.998.5085.6364
Decreasing
Very volatile
Dividend Yield0.04060.0380.0347
Increasing
Slightly volatile
Current Ratio1.10.7941.5452
Decreasing
Stable
Free Cash Flow per Share10.0512.4246.1918
Increasing
Slightly volatile
Book Value per Share9.398.7053.4312
Increasing
Very volatile
Tangible Assets Book Value per Share20.921.58116.0638
Increasing
Slightly volatile
Total Assets Per Share89.4182.862643.3808
Increasing
Slightly volatile
Cash Flow Per Share13.8912.88056.8025
Increasing
Slightly volatile
Return on Investment23.9118.746624.3541
Decreasing
Slightly volatile
Operating Margin29.0231.894929.0467
Increasing
Stable
Calculated Tax Rate11.9111.086310.6119
Decreasing
Slightly volatile
Receivables Turnover5.495.97875.52
Increasing
Slightly volatile
Inventory Turnover4.775.41974.6361
Increasing
Stable
PPandE Turnover9.8110.85099.5795
Increasing
Slightly volatile
Cash and Equivalents Turnover6.346.1772148
Decreasing
Slightly volatile
Accounts Payable Turnover9.66.26513.4153
Decreasing
Slightly volatile
Accrued Expenses Turnover10.7911.860910.2707
Increasing
Slightly volatile
Interest Coverage7.717.518596.3284
Decreasing
Slightly volatile
Long Term Debt to Equity4.564.1665.3971
Increasing
Stable
Quick Ratio0.580.56281.1617
Decreasing
Stable
Net Current Assets as percentage of Total Assets(5.09)(4.9587)12.7529
Decreasing
Slightly volatile
Revenue to Assets0.510.38350.5399
Decreasing
Slightly volatile

Abbvie Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings before Tax10.5 B13 B6.4 B
Increasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization EBITDA25.8 B23.9 B10.5 B
Increasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization USD25.8 B23.9 B10.5 B
Increasing
Slightly volatile
Market Capitalization205.7 B239.4 B130.6 B
Increasing
Slightly volatile
Enterprise Value261.2 B307.9 B159.4 B
Increasing
Slightly volatile
Invested Capital59.6 B69.9 B38.3 B
Increasing
Slightly volatile
Average Equity14.9 B13.8 B6.5 B
Decreasing
Very volatile
Average Assets160.2 B148.5 B67.1 B
Increasing
Slightly volatile
Invested Capital Average62.5 B77.7 B36.9 B
Increasing
Slightly volatile
Tangible Asset Value35.4 B38.2 B25.8 B
Increasing
Slightly volatile
Free Cash Flow23.7 B22 B10.6 B
Increasing
Slightly volatile
Working Capital(7.5 B)(7.3 B)4.5 B
Decreasing
Stable
Revenue Per Employee970.2 K1.1 M880.2 K
Increasing
Slightly volatile
Net Income Per Employee195.7 K230.8 K172.9 K
Increasing
Slightly volatile

Abbvie Fundamental Market Drivers

Short Percent Of Float0.75%
Forward Price Earnings12.83
Shares Short Prior Month13.44M
Average Daily Volume Last 10 Day7.11M
Average Daily Volume In Three Month7.32M
Date Short Interest29th of April 2022
Fifty Day Average149.83
Two Hundred Day Average136.88

Abbvie Upcoming Events

Upcoming Quarterly Report2nd of February 2022
Next Financial Report29th of April 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End2nd of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

About Abbvie Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Abbvie income statement, its balance sheet, and the statement of cash flows. Abbvie investors use historical funamental indicators, such as Abbvie's revenue or net income, to determine how well the company is positioned to perform in the future. Although Abbvie investors may use each financial statement separately, they are all related. The changes in Abbvie's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Abbvie's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Abbvie Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Abbvie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Cost of Revenue17.4 B18.8 B
Revenues56.2 B46.4 B
Revenue to Assets 0.38  0.51 
Revenue Per Employee1.1 M970.2 K
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. Abbvie operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 50000 people.

Abbvie Investors Sentiment

The influence of Abbvie's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Abbvie. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Abbvie's public news can be used to forecast risks associated with investment in Abbvie. The trend in average sentiment can be used to explain how an investor holding Abbvie can time the market purely based on public headlines and social activities around Abbvie Inc. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Abbvie's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Abbvie's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Abbvie's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Abbvie.

Abbvie Implied Volatility

    
  24.19  
Abbvie's implied volatility exposes the market's sentiment of Abbvie Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Abbvie's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Abbvie stock will not fluctuate a lot when Abbvie's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abbvie in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abbvie's short interest history, or implied volatility extrapolated from Abbvie options trading.

Current Sentiment - ABBV

Abbvie Inc Investor Sentiment

Majority of Macroaxis users are presently bullish on Abbvie Inc. What is your sentiment towards investing in Abbvie Inc? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Pair Trading with Abbvie

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbvie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbvie will appreciate offsetting losses from the drop in the long position's value.

Abbvie Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Abbvie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbvie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbvie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbvie Inc to buy it.
The correlation of Abbvie is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbvie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbvie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbvie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to the analysis of Abbvie Correlation against competitors. Note that the Abbvie Inc information on this page should be used as a complementary analysis to other Abbvie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Abbvie Stock analysis

When running Abbvie Inc price analysis, check to measure Abbvie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbvie is operating at the current time. Most of Abbvie's value examination focuses on studying past and present price action to predict the probability of Abbvie's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbvie's price. Additionally, you may evaluate how the addition of Abbvie to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Is Abbvie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbvie. If investors know Abbvie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbvie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Abbvie Inc is measured differently than its book value, which is the value of Abbvie that is recorded on the company's balance sheet. Investors also form their own opinion of Abbvie's value that differs from its market value or its book value, called intrinsic value, which is Abbvie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbvie's market value can be influenced by many factors that don't directly affect Abbvie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbvie's value and its price as these two are different measures arrived at by different means. Investors typically determine Abbvie value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbvie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.